SEOUL, South Korea, Nov. 30, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading m...
* Q3 Revenue held steady at KRW 305.3 billion * Operating profit dipped slight due to powerful i...
SEOUL, South Korea, Nov. 15, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a leading biotechnology...
* A true walk away 'sample to answer' molecular diagnostic system designed for high throughput tes...
* Seegene unveils its first fully automated MDx system, STARlet-AIOS: All-in-One System at the 20...
SEOUL, South Korea, Sept. 1, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading m...
- Revenue of KRW 303.7 billion ($269.1 million) is record for second quarter, up 11 percent year-o...
* Seegene launches new multiplex PCR test capable of screening six SARS-CoV-2 variants including ...
* Seegene announces partnership with Bio-Rad for the development and commercialization of infecti...
* Seegene unveils "MOBILE STATION" at the Medlab Middle East 2021 * Mobile laboratory designed f...
* SEEGENE POSTS KRW 193.9 BIL. IN OPERATING PROFIT, UP 388% ON-YEAR * OPERATING PROFIT RATIO AT ...
SEOUL, Korea, May 24, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a biotechnology firm specializ...
We are advised by Seegene Inc. that journalists and other readers should disregard the news releas...
* SEEGENE BACKS GERMANY IN ITS EFFORT TO RETURN TO NORMALCY * GERMAN SUBSIDIARY TO SUPPLY COVID-...
* Second public procurement agreement after Italy's procurement deal worth EUR 89.3 million SEOUL...
* Seegene's Italian subsidiary to supply some 7.15 million COVID-19 tests to 17 regions there *...
* Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people ...
SEOUL, South Korea, April 9, 2021 /PRNewswire/ -- South Korea's leading molecular diagnostics firm ...
* Seegene's new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 minute...
SEOUL, South Korea, Feb.18, 2021 /PRNewswire/ -- South Korea's leading molecular diagnostics firm S...